The European Tribune is a forum for thoughtful dialogue of European and international issues. You are invited to post comments and your own articles.
Please REGISTER to post.
Not a lot of people have taken remdesivir. Serious and unexpected side effects may happen.
like hydroxycholoroquine, but not
"Remdesivir" (brand name of licensed USAMRID patent) appeared in the "public domain" ostensibly to treat ebola in 2014 and again 2018 to present, I might have mentioned more than once.
Neither it nor hydroxycholorquine (compound generic) is approved by FDA for treatment of COVID-19. And both are EAU authorized by FDA for ("off-label") treatment of COVID-9, cover-story, clinical trial of "investigational" (formerly known as "experimental") drug. NIAID's trial design (linked above) is suspiciously comprehensive and detailed, given purported inexperience with this "biologic" drug's active ingredients, forensic disposition, and therapeutic efficacy.
FDA's public notice alerts prospective trial-subjects and parents [?!] to known and unspecified side-effects that may occur with application. While such notice does not represent an informed consent agreement, I note with interest that the US Congress is preparing to indemnify any and all commercial establishments from tort claims relating SARS-COv-2 infection to exposure on premises. One several "trial balloons" floated by press in last three weeks, U.S. Republicans push for coronavirus lawsuit immunity for business, to which no opposition has appeared.
Part of the myth of the American identity is the extreme loathing of government. Somewhere in our history, government came to mean, specifically, the state. Private government, or the private sector, was positively not the government. The idea of private government, i.e. an institution that controls a large portion of our lives, has never been more important than it is now. In "Private Government: How Employers Rule Our Lives (And Why We Don't Talk About It)," Elizabeth Anderson discusses at length how the free market, as imagined by 18th and 19th century thinkers such as Adam Smith and Thomas Paine, was supposed to be a "levelling" force that gave more liberty to individuals. They imagined a society comprised mostly of people who worked for themselves, or companies that were quite small. Smith's famous pin factory in which he explained his theory of division of labor had 10 people and it was thought to be large. The massive corporations of today and the power they exert do not reflect that vision.
In "Private Government: How Employers Rule Our Lives (And Why We Don't Talk About It)," Elizabeth Anderson discusses at length how the free market, as imagined by 18th and 19th century thinkers such as Adam Smith and Thomas Paine, was supposed to be a "levelling" force that gave more liberty to individuals. They imagined a society comprised mostly of people who worked for themselves, or companies that were quite small. Smith's famous pin factory in which he explained his theory of division of labor had 10 people and it was thought to be large. The massive corporations of today and the power they exert do not reflect that vision.
#WhereIsOSHA is not trending, and @ewarren is flogging another plan for a plan, billed as the "Essential Workers Bill of Rights" notwithstanding the imprimatur of random "Black or African American" clergy and URGENCY of enforcing OBSCURE provisions of 29 U.S.C., one might suppose.
remdesivir was found to shorten the duration of illness [by 30%!] in patients with severe COVID-19, but it had no statistically significant effect on whether patients died. [...] Gilead has donated 1.5 million vials of the drug, O'Day said, which amounts to between 100,000 and 200,000 treatment courses, depending on how long patients take it. "This donation will be made available to patients here in America in the United States and across the world, as other regulatory decisions are taken for those countries," he said. [...] In a press release on Friday, Gilead said its goal is to produce at least 500,000 treatment courses by October and more than a million by December. The FDA-authorized drug is infused through an IV, and its use is limited to hospitalized patients with severe disease. But O'Day said Gilead is looking at other formulations of remdesivir too -- including an inhaled version that could be given outside of the hospital.
"This donation will be made available to patients here in America in the United States and across the world, as other regulatory decisions are taken for those countries," he said. [...] In a press release on Friday, Gilead said its goal is to produce at least 500,000 treatment courses by October and more than a million by December.
The FDA-authorized drug is infused through an IV, and its use is limited to hospitalized patients with severe disease. But O'Day said Gilead is looking at other formulations of remdesivir too -- including an inhaled version that could be given outside of the hospital.
by gmoke - Nov 30
by gmoke - Nov 24
by gmoke - Nov 7
by gmoke - Nov 11
by Oui - Dec 7
by Oui - Dec 6
by Oui - Dec 61 comment
by Oui - Dec 51 comment
by Oui - Dec 4
by Oui - Dec 3
by Oui - Dec 312 comments
by Oui - Dec 2
by Oui - Dec 1
by Oui - Nov 303 comments
by Oui - Nov 302 comments
by Oui - Nov 30
by Oui - Nov 29
by Oui - Nov 28
by Oui - Nov 288 comments
by Oui - Nov 283 comments
by Oui - Nov 277 comments